about
Glucosamine for osteoarthritis: biological effects, clinical efficacy, and safety on glucose metabolismPPARs: Protectors or Opponents of Myocardial Function?The role of glucosamine-induced ER stress in diabetic atherogenesisUsing extracellular matrix proteomics to understand left ventricular remodelingO-GlcNAcylation and oxidation of proteins: is signalling in the cardiovascular system becoming sweeter?O-linked β-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cellsCardiac stem cell therapy for cardiac repair.Aging leads to elevation of O-GlcNAcylation and disruption of mitochondrial homeostasis in retina.The regulatory roles of O-GlcNAcylation in mitochondrial homeostasis and metabolic syndrome.Finding the missing link between the unfolded protein response and O-GlcNAcylation in the heart.O-linked β-N-acetylglucosamine transferase is indispensable in the failing heart.Endothelial cell metabolism: parallels and divergences with cancer cell metabolismMicroRNA-539 is up-regulated in failing heart, and suppresses O-GlcNAcase expression.O-GlcNAcylation: a novel pathway contributing to the effects of endothelin in the vasculature.Protein O-GlcNAcylation and cardiovascular (patho)physiology.Diabetes and retinal vascular dysfunction.Identification of O-GlcNAc modification targets in mouse retinal pericytes: implication of p53 in pathogenesis of diabetic retinopathy.High glucose induces mitochondrial dysfunction independently of protein O-GlcNAcylation.O-GlcNAc signaling is essential for NFAT-mediated transcriptional reprogramming during cardiomyocyte hypertrophy.The augmentation of O-GlcNAcylation reduces glyoxal-induced cell injury by attenuating oxidative stress in human retinal microvascular endothelial cells.Removal of Abnormal Myofilament O-GlcNAcylation Restores Ca2+ Sensitivity in Diabetic Cardiac Muscle.O-GlcNAcase overexpression reverses coronary endothelial cell dysfunction in type 1 diabetic mice.Overview: the maturing of proteomics in cardiovascular research.Post-translational protein modification by O-linked N-acetyl-glucosamine: its role in mediating the adverse effects of diabetes on the heart.Enhanced cardiac protein glycosylation (O-GlcNAc) of selected mitochondrial proteins in rats artificially selected for low running capacity.Circulating N-Linked Glycoprotein Acetyls and Longitudinal Mortality Risk.Downregulation of O-linked N-acetylglucosamine transferase by RNA interference decreases MMP9 expression in human esophageal cancer cells.Retinal O-linked N-acetylglucosamine protein modifications: implications for postnatal retinal vascularization and the pathogenesis of diabetic retinopathy.Identification of O-linked β-D-N-acetylglucosamine-modified proteins from ArabidopsisDynamic O-GlcNAcylation and its roles in the cellular stress response and homeostasis.STIM1/Orai1-mediated SOCE: current perspectives and potential roles in cardiac function and pathologyCardiac metabolism in heart failure: implications beyond ATP production.Cardiomyocyte Ogt is essential for postnatal viability.O-GlcNAc and the cardiovascular system.Nutrient-driven O-GlcNAc cycling - think globally but act locally.Metabolic fingerprint of ischaemic cardioprotection: importance of the malate-aspartate shuttle.Protein O-linked β-N-acetylglucosamine: a novel effector of cardiomyocyte metabolism and function.Protein O-GlcNAcylation in diabetes and diabetic complications.Therapeutic strategies impacting cancer cell glutamine metabolism.Chemical tools to explore nutrient-driven O-GlcNAc cycling.
P2860
Q21284705-EBA49C1C-0CDF-407E-9BDD-F7C36900DDC8Q26771753-9682519B-302E-4C41-AB76-B08D59A3B47BQ26830592-93C6F578-B7F3-4324-A22F-505AB26C88C7Q26863127-F8C53437-BB90-405C-A9EF-6B01128BA316Q27693206-6C6F2963-9641-45D4-869B-5486102AEBECQ28569862-BEE46047-8AB0-457C-837B-8C66D3BE8F9AQ33749374-7A941185-CB89-451B-9B4E-6CF737266B61Q33765402-30950E47-3BB2-4E4F-B2A0-1DDDAE9885FDQ33782985-BDA8A78A-5E21-4357-A302-80DB5DB34D76Q34127646-C4BE86F8-00F1-49BB-9632-719C7E25C299Q34199818-655EE7AB-5510-4E06-A449-D52677A3250BQ34228247-E147A392-C915-40B6-A090-97E137B66811Q34396795-B2DA7D32-B041-450E-BFBB-24E07657E795Q34598611-578FAE29-AB8C-42B0-A52A-C265EACC2992Q34683061-8981FE5C-6B10-4634-AC25-77AC3649D1A6Q35017752-F080777F-9F6F-4CC6-BD2E-AB524C83180AQ35161621-5D036570-DFA2-4604-A441-B23A6D7BD798Q35535273-33DEF0A3-ABB6-4578-8FE9-BE879215D30BQ35994150-41FB840A-4785-4F62-B8E8-6A76B8712AC4Q36041756-87B430D2-E94F-4806-912A-7260565071FCQ36104643-22CD34DF-2DF6-43FF-B7EE-7679A3A881B5Q36237060-50E511E1-8515-43E8-84B8-5BF58F8BD048Q36406428-AEE12AB5-6773-4F18-87D7-BD003FC16370Q36484390-AF3FA600-222A-4B1C-AE06-9A8980741F99Q36530879-9A8B56E8-B1B5-499F-BFD5-7813199262DDQ36811443-182CF560-4D2E-44EA-8866-BF0C72D373B4Q36825392-95E8798A-D484-47E0-9608-1A09E16FA645Q36890350-C2CD1442-DCC0-471B-AAA7-BD6AE7E315C9Q36976117-26DE4E6A-AA23-4495-8545-145752317C27Q37099485-9B15FCEA-BD5A-45D9-8158-09584C5BAD19Q37476541-385D0B4D-0FC8-4302-9E86-7C67A2F11057Q37495811-1A705D94-763B-45FB-B26F-D67B4B021309Q37575982-097DFCDA-E368-44DB-95A8-6045DA514A34Q37619691-5ECAF233-2D0A-4D83-B0B8-D6EB2E606405Q37732989-53116957-3BAE-45E5-A371-18927EABACEDQ37846991-E368E0AC-BAA7-4978-A7AB-5BF00C532CFCQ37924015-91DB9AD0-AB35-4934-8186-8A8713176062Q38132916-B0AB4944-0961-411E-B6E5-F9B29DAAFAD1Q38139096-19A36DDF-1A15-43D9-B06F-3A59BAD35DD2Q38231368-93A282E7-8192-46B8-9560-0A2BB919FAC9
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
O-GlcNAc signaling in the cardiovascular system.
@ast
O-GlcNAc signaling in the cardiovascular system.
@en
O-GlcNAc signaling in the cardiovascular system.
@nl
type
label
O-GlcNAc signaling in the cardiovascular system.
@ast
O-GlcNAc signaling in the cardiovascular system.
@en
O-GlcNAc signaling in the cardiovascular system.
@nl
prefLabel
O-GlcNAc signaling in the cardiovascular system.
@ast
O-GlcNAc signaling in the cardiovascular system.
@en
O-GlcNAc signaling in the cardiovascular system.
@nl
P2093
P2860
P1433
P1476
O-GlcNAc signaling in the cardiovascular system.
@en
P2093
Ayesha Zafir
Gladys A Ngoh
Steven P Jones
P2860
P304
P356
10.1161/CIRCRESAHA.110.224675
P577
2010-07-01T00:00:00Z